comparemela.com
Home
Live Updates
Santhera Receives Approval for AGAMREE® (Vamorolone) as a : comparemela.com
Santhera Receives Approval for AGAMREE® (Vamorolone) as a
Approval by the Medicines and Healthcare products Regulatory Agency (MHRA) of AGAMREE® in the United Kingdom follows marketing authorization for this...
Related Keywords
Switzerland
,
United States
,
United Kingdom
,
Germany
,
Pratteln
,
Switzerland General
,
America
,
Swiss
,
Shabir Hasham
,
Eva Kalias
,
European Medicines Agency
,
America To Catalyst Pharmaceuticals
,
European Union
,
Life Science Alliance
,
Head Investor Relations Communications
,
Regulatory Agency
,
Santhera Pharmaceuticals Holding
,
Santhera Pharmaceuticals
,
Duchenne Research Fund
,
Energyx Ray Absorptiometry
,
European Commission
,
Drug Administration
,
Chief Medical Officer
,
Emily Reuben
,
Chief Executive
,
Duchenne United Kingdom
,
Alex Johnson
,
Joining Jack
,
Duchenne United
,
Dual Energyx Ray Absorptiometry
,
Orphan Drug
,
Fast Track
,
Rare Pediatric Disease
,
Promising Innovative Medicine
,
Product Characteristics
,
Proc Natl Acad Sci United States
,
United Kingdom Medicines
,
North America
,
Catalyst Pharmaceuticals
,
Head Investor Relations
,
Swiss Stock Exchange Sann
,
Santhera Pharmaceuticals Holding Ag
,
comparemela.com © 2020. All Rights Reserved.